title: The discrepancy between central foveal thickness and best corrected visual acuity in cystoid macular edema secondary to central retinal vein occlusion after intravitreal lucentis® injection.
abstract: Cystoid macular edema is a common retinal disorder with the potential for significant vision-related morbidity, and intravitreal lucentis(®) injection is confirmed to be an effective therapy approach. In the present study, we investigated the discrepancy between central foveal thickness and best corrected visual acuity in such lesions and infered that intravitreal lucentis(®) injection may help the visual function, related to the renewal of cells.
authors.affiliation: Department of Ophthalmology, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
authors.forename: Rui
authors.initials: R
authors.lastname: Hua
authors.affiliation: Department of Endocrinology, First Hospital of China Medical University, Shenyang, China; Key Laboratory of Endocrine Diseases in Liaoning Province, First Hospital of China Medical University, Shenyang, China. Electronic address: chenyan830424@126.com.
authors.forename: Chenyan
authors.initials: C
authors.lastname: Li
authors.affiliation: Department of Ophthalmology, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
authors.forename: Yuedong
authors.initials: Y
authors.lastname: Hu
authors.affiliation: Department of Ophthalmology, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Chen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005584:Fovea Centralis / Q000473:pathology; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology*; D000069579:Ranibizumab / Q000008:administration & dosage / Q000627:therapeutic use*; D012170:Retinal Vein Occlusion / Q000150:complications*; D014792:Visual Acuity; D055815:Young Adult
chemical_list: D020533:Angiogenesis Inhibitors; D000069579:Ranibizumab
keywords: Anti-VEGF therapy; Best corrected visual acuity; Central foveal thickness; Cyst area; Cystoid macular edema; Optical coherence tomography